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Abstract
Active efflux due to tripartite RND efflux pumps is an important mechanism of clinically rele-
vant antibiotic resistance in Gram-negative bacteria. These pumps are also essential for
Gram-negative pathogens to cause infection and form biofilms. They consist of an inner
membrane RND transporter; a periplasmic adaptor protein (PAP), and an outer membrane
channel. The role of PAPs in assembly, and the identities of specific residues involved in
PAP-RND binding, remain poorly understood. Using recent high-resolution structures, four
3D sites involved in PAP-RND binding within each PAP protomer were defined that corre-
spond to nine discrete linear binding sequences or “binding boxes” within the PAP
sequence. In the important human pathogen Salmonella enterica, these binding boxes are
conserved within phylogenetically-related PAPs, such as AcrA and AcrE, while differing con-
siderably between divergent PAPs such as MdsA and MdtA, despite overall conservation of
the PAP structure. By analysing these binding sequences we created a predictive model of
PAP-RND interaction, which suggested the determinants that may allow promiscuity
between certain PAPs, but discrimination of others. We corroborated these predictions
using direct phenotypic data, confirming that only AcrA and AcrE, but not MdtA or MsdA,
can function with the major RND pump AcrB. Furthermore, we provide functional validation
of the involvement of the binding boxes by disruptive site-directed mutagenesis. These
results directly link sequence conservation within identified PAP binding sites with functional
data providing mechanistic explanation for assembly of clinically relevant RND-pumps and
explain how Salmonella and other pathogens maintain a degree of redundancy in efflux
mediated resistance. Overall, our study provides a novel understanding of the molecular
determinants driving the RND-PAP recognition by bridging the available structural informa-
tion with experimental functional validation thus providing the scientific community with a
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predictive model of pump-contacts that could be exploited in the future for the development
of targeted therapeutics and efflux pump inhibitors.
Author summary
Active efflux due to tripartite efflux pumps is an important mechanism of clinically rele-
vant antibiotic resistance in Gram-negative bacteria. In this study, we have defined for the
first time the residue ranges of the PAPs that are involved in the assembly of the major tri-
partite efflux systems in Salmonella and E. coli based on structural analysis and functional
data. The analysis of conservation within these residue ranges allowed prediction of which
PAPs that are able to function with the major efflux pump, AcrB. Further direct validation
of the critical roles of these residue ranges by site-directed mutagenesis, allowed us to dra-
matically narrow the PAP-binding surface determinants. Overall, our study provides a
novel understanding of the molecular determinants driving the RND-PAP recognition by
bridging the available structural information with experimental functional validation thus
providing the scientific community with a predictive model of pump-contacts that could
be exploited in the future for the development of targeted therapeutics.
Introduction
The incidence of multidrug resistant (MDR) infections is increasing globally and the need to
understand the mechanisms of this resistance is paramount in order to develop novel thera-
peutics. Efflux pumps are an important mechanism of antibiotic resistance because they are
able to pump diverse antimicrobial compounds out of bacterial cells [1]. Of particular rele-
vance to the issue of MDR infections are the tripartite efflux-systems in Gram-negative bacte-
ria, which are composed of an inner membrane pump (typically belonging to the Resistance,
Nodulation, Division or RND-family), an outer membrane channel and a periplasmic adaptor
protein (PAP) (previously known as the membrane fusion protein) [2]. The tripartite pumps
built around the RND family of transporters are the most clinically relevant class and are
found in all Gram-negative bacteria with AcrAB-TolC being the principal RND efflux system
in Salmonella, Escherichia coli and other Enterobacteriaceae [3]. It confers intrinsic resistance
to multiple, structurally distinct antimicrobials including clinically and veterinary relevant
classes such as the β-lactams and quinolones. Over-expression of AcrAB-TolC, or homologous
RND efflux pumps in other species, confers MDR and is a common resistance mechanism
found in bacterial isolates from humans and animals [4, 5]. RND efflux pumps are also funda-
mental to the biology of Gram-negative bacteria; for example AcrB and TolC mutants had
impaired biofilm formation [6, 7] and attenuated virulence including reduced colonisation of
chickens [8, 9]. This multi-faceted role in the biology of Gram-negative bacteria makes these
pumps attractive targets for the development of inhibitors.
Genomes of Gram-negative bacteria encode multiple RND-transporters which pair with a
number of PAPs forming a variety of efflux systems with different substrate profiles and dis-
tinct cellular roles [8, 10–15]. Salmonella has five RND transporters (AcrB, AcrD, AcrF, MdtB/
C and MdsB) while E. coli has six and Pseudomonas aeruginosa has more than ten. AcrAB is
the principal RND system in E. coli and Salmonella as it is highly expressed and has the broad-
est substrate range. AcrEF has a similar substrate range but is expressed at much lower levels
[8, 16]. Salmonella has only four PAPs as AcrD is not encoded alongside its own PAP and
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requires AcrA for function showing that there is some promiscuity between components of
RND systems [17]. In addition, we have previously suggested that AcrE can function with
AcrB [18] and in E. coli AcrA has been shown to function with AcrF [19]. In contrast, there
are a limited number of outer membrane channels belonging to the outer-membrane factor
(OMF) family [20] compared to a seemingly large variety of PAP-transporter pairs. For exam-
ple, TolC is the cognate channel for many pumps including AcrAB, AcrEF, AcrAD and
MdtABC [20]. This is partially because the OMFs are non-specific conduits that are promiscu-
ous at the level of cargo, leaving the selection of the substrate to the transporter. The obvious
promiscuity on the level of OMF-PAP has focused the attention of the scientists in the efflux
field and left the recognition between the PAP and (RND)-transporter less studied. These
interactions however are crucial for assembly of active efflux complexes, and the potential to
interchange the PAP used in an efflux system may provide the bacteria with adaptability and
plasticity to circumvent antibacterial agents. In addition, the PAPs themselves have previously
been highlighted as good targets against which to develop inhibitor molecules [18, 21, 22]
making understanding these interactions increasingly important.
Recent advances in structural understanding of tripartite pump organisation, in particular
the development of cryo-EM approaches have allowed a glimpse of the complete assembly.
Structures, including the engineered E. coli AcrAB-TolC complex [23]; the structure of disul-
fide-stabilised AcrAB-TolC [24], as well as the structures of related MacAB-TolC [25] and
lower-resolution native-state MexAB-OprM [26] have provided a near-atomic resolution of
the interactions within the pumps and elucidated critical aspects of their energetics and pump-
ing mechanisms. These advances now allow dissection of the protein-protein interactions
underlying assembly of these pumps, an understanding that may be critical for development of
inhibitors of efflux.
The general structure of the RND-efflux pumps as revealed by these data shows an arrange-
ment of 3:6:3 protomers of the OMF, PAP and RND-transporter respectively. The PAP-RND
pairs seem to exist in a pre-assembled state, forming a stable binary complex (Fig 1A) [27] that
can be isolated and in some cases crystallised as shown for the CusBA metal transporter [28].
The structure of AcrB is shown and described in S1 Fig. The modularity and duplication
observed within each RND subunit results in the creation of a pair of semi-equivalent binding
sites on the surface of each RND protomer, each supposed to engage with a single PAP
although the exact binding mode remains debatable [23, 29, 30]. While in some transporters
these two sites are occupied by two separate, dedicated PAPs [e.g. TriABC pump, 31] in the
case of AcrAB there are two copies of AcrA per protomer of AcrB which we will refer to as
PAP1 and PAP2 (Figs 1A and 2A).
The structures of RND-associated PAPs have been studied in many species [28, 30, 32, 33]
although there is no direct structural data available in Salmonella. The PAPs have a hairpin-
like arrangement with the polypeptide chain beginning at the inner membrane, crossing the
periplasm to bridge the outer membrane component of the efflux complex in the middle of the
protein and then folding back on itself with the C-terminal being located close to the N-termi-
nal at the inner membrane (Fig 1C) [2]. It is thought that the PAPs provide a link to the OMF
(such as TolC) through the α-helical hairpin domain, which has a coiled coil arrangement and
may engage with the coiled-coil hairpins of the OMF either by formation of helical bundles
[29, 30] or in a tip-to-tip cogwheel-fashion [24, 34] depending on the model of assembly. Adja-
cent to the hairpin is the lipoyl domain which is composed of four β-strands and is required
for interaction of PAPs with each other within the efflux complex [24]. The β -barrel domain is
composed of six antiparallel β-strands capped by a single α-helix and is flexibly linked to the
membrane proximal (MP) domain. The membrane proximal (MP) domain is formed from
the N- and C-terminal regions of the polypeptide and has a beta-roll organisation topologically
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related to the β -barrel domain [2] (Fig 1C). The MP domain appears to form extensive con-
tacts with the porter-domains of the RND pumps [24] and has been shown to play an impor-
tant role in substrate acquisition and presentation to the metal-pumping RND transporters
[33]. Furthermore in the related ABC-transporter-associated PAPs such as MacA the MP
Fig 1. A. A general view of the PAP-RND assembly as exemplified by the E. coli AcrAB sub-complex seen in the asymmetric cryo-EM structure (5o66.pdb) [24]. B.
AcrB trimer organisation illustrated by side view of the AcrB trimer from the same assembly as in 1A. Protomers coloured with different colours and principal domains
indicated. C. Domain organisation of a typical PAP based on the experimental structure of E.coli AcrA (protomer G from 5o66.pdb above). The chain is coloured in
rainbow from N-terminus (blue) to C-terminus (red).
https://doi.org/10.1371/journal.ppat.1008101.g001
Fig 2. A. Positions of PAP1 (violet) and PAP2 (red) protomers relative to RND-protomer within the assembly exemplified by the AcrAB sub-complex discussed in Fig 1
above. Binding is discussed relative to the green protomer of AcrB. B. Binding regions of PAP1 relative to the RND protomer (using AcrA chain G in 5o66.pdb for
illustration). The region of PAP1-RND interaction is magnified and annotated highlighting the 4 principal binding sites and structural features of the surface. Further
details provided in the text. C. PAP2 –RND binding regions on the example of AcrA (chain H) in 5o66.pdb.
https://doi.org/10.1371/journal.ppat.1008101.g002
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domain appears to be involved in cargo selection and discrimination [35] and activates the
ATPase activity of the transporter [36] making this domain a potential target for pump inhibi-
tor design.
Here, we have capitalised on these recent functional insights and combined them with the
aforementioned structural biology breakthroughs to determine which PAP residues are
involved in the interaction with RND pumps in Salmonella. To this end we analysed available
docked structures of PAP and RND efflux pumps and showed that the regions of PAP-trans-
porter contact are relatively compact and discrete. Based on homology models of the PAPs in
Salmonella we found these regions to be highly conserved between AcrA and AcrE but diver-
gent in the other two PAPs—MdtA and MdsA. We furthermore demonstrate that this conser-
vation of binding sites translates into functional promiscuity and redundancy between AcrA
and AcrE that manifests in their ability to support efflux function through the major trans-
porter AcrB, while the PAPs lacking conservation in these regions, MdtA and MdsA, cannot.
Our findings elucidate residues within PAPs that are important for RND-transporter binding
providing a unified framework for future structure-function analysis and also confirm that
AcrA and AcrE can function interchangeably which will have implications for the design of
efflux inhibitors.
Results
Discrete stretches of residues control PAP-RND contact and recognition of
the cognate PAP-RND pairs is vetted by a small number of “discriminator”
residues
The PAPs have been identified, by us and others, as excellent targets for the development of
efflux inhibitors [18, 21, 22] but knowledge of the exact PAP residues important for efflux
complex recognition and assembly is limited. The recent near-atomic resolution cryo-EM
structures of the stabilized tripartite complex of AcrAB-TolC [24] allow examination of the
PAP residues involved in RND-transporter binding. Mapping of the transporter-binding
regions derived from the experimental structures reveals several discrete stretches of residues
involved in contact. The contacts are provided exclusively from the β-barrel and MP domains
(Figs 1A and 2A), while the lipoyl domain is involved in self-association, and the α-helical
domains, provide both a contact with the OMF and self-associate to provide a tight seal of the
efflux conduit in agreement with the so-called tip-to-tip or cogwheel models of assembly [37].
We analysed the available cryo-EM data, of assembled AcrA-AcrB complexes, to define
possible interacting residues. PAPs bind RND transporters in a 2:1 stoichiometry. This results
in two protomers of the PAP binding to one protomer of the transporter at different semi-
equivalent binding sites with slightly different specificities and affinities [27]. Here we refer to
the two PAP positions as PAP 1 and PAP2 (Figs 1A and 2A). Despite the pore domain of
AcrB, being composed of the two semi-equivalent lobes (PN1/PC2 and PN2/PC1 respectively)
(Fig 2B and in more detail in S1 Fig) our analysis shows that the binding of the AcrA proto-
mers to the surface of the AcrB is strongly asymmetrical, with the binding sites for PAP1 being
restricted primarily to the surface of PC1 subdomain of the main protomer to which it is
bound, as well as the surface of the funnel-subdomain (Cβ7-Cβ12 hairpin, Cα4 helix and β-
hairpin2), with additional strong contribution from the Nβ8-Nβ9 hairpin of the neighbouring
AcrB protomer. However, the PAP2 protomer is primarily restricted to the PN2 subdomain of
the core AcrB protomer, but also makes contact with the alpha-hairpin of the following AcrB
subunit, as well as the funnel domain. The two PAP protomers hence display a significant dis-
crepancy of conformational arrangement, which is expressed primarily in the relative orienta-
tion of the MP and β-barrel domains (Figs 2 and S3A). This is further exacerbated by the
Identifying the interactions driving the RND-PAP recognition
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asymmetry of the AcrB trimers, which results directly from the conformational cycling associ-
ated with the pump’s peristaltic function [38, 39]. However, our analysis shows that despite the
binding sites on the RND-side being markedly different, essentially the same PAP residues are
involved in binding to both, and hence description of the binding sites from the viewpoint of
the PAP is easier, as the sites are broadly the same between all 6 PAP protomers, with only
some minor deviations. While the exact side-chain orientations may be difficult to deduce due
to the medium-to-low resolution of the available structures, they are reliable enough on the
level of C-alpha traces, and to define possible binding sites we have considered as “plausible”
contacts extending to Cα-Cα distance of 11 Å to account for the level of coordinate uncer-
tainty [40]. Four regions of PAP-contact fulfilling these distance criteria relative to AcrB were
defined per AcrB structural repeat, and while some of the contact residues differ depending on
the conformation, the key interacting regions remain the same in both PAP protomers. The
four discrete “binding sites” in AcrA have been arbitrarily numbered from 1 to 4 (Fig 2B and
2C) and are briefly described below:
Site 1: β-barrel domain of PAP 1 to the funnel-domain (DN) of the main RND protomer
(alpha-helical fragment Nα4 in Murakami 2002 nomenclature and base of the β-hairpin1)
or β-barrel of PAP 2 to the DC domain of the neighbouring RND protomer (α-helical frag-
ment Cα4 and base of β-hairpin2).
Site 2: PAP β-barrel domain to β-hairpin of the RND funnel domain (PAP 1- β-hairpin 2 of
DC; PAP2 – β-hairpin 1 of DN).
Site 3: PAP MP-domain to base of RND funnel domain.
Site 4: PAP MP-domain to RND pore (porter)-domain (in the case of PAP1 to PC1; in the
case of PAP2 to PN2).
It is striking, that despite the extensive surface area available for a tight interaction between
the PAP and the transporter, the two proteins seem to have relatively limited contact, with the
main stabilising interactions being restricted to the self-association of the lipoyl domains of
the PAPs. This observation by itself directly leads to the suggestion, that from the relatively few
remaining contacts, a number will have to be generally preserved for structural rigidity and
may be conserved in nature across the PAP-transporter pairs, while a smaller number still will
play the role of “discriminators” requiring exact pairing between the PAP and its cognate
transporter.
Taking these considerations into account and to simplify the analysis of the binding sites
we have divided them into their actual linear sequence constituents and numbered them from
N-terminus to the C-terminus of the PAP (using AcrA as a template). This resulted in 9 dis-
crete “binding boxes” to which we will refer further in the text. They are visualized in the struc-
tural alignment (Fig 3A) and mapped onto the structure of the E. coli AcrA on Fig 3B. A more
detailed comparison is provided in S3 Fig.
Homology modelling of Salmonella PAPs reveals two clear structural
clusters
To understand more about how these PAP “binding boxes” are conserved amongst the PAP
family we conducted further work in Salmonella. We have previously reported that the PAPs
in S. enterica display some promiscuity [18] and Salmonella is an excellent model that enables
study not only of drug resistance phenotypes, but also the effect of efflux on infection. At pres-
ent there is no direct structural data available for any of the five RND pumps or the four PAPs
in the important human pathogen Salmonella. Even for E. coli, structural information for
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RND-pumps other than AcrAB is not available. Therefore, homology models of Salmonella
PAPs were designed to allow for structural analysis and sequence conservation mapping. We
were able to construct reliable models of Salmonella AcrA based on the direct correspondence
of the sequence between it and the experimentally determined partial E. coli structures [32], as
well as the full-length cryo-EM structures [24] and the full-length structures of the related
MexA from P. aeruginosa [30].
Based on our analysis, all four Salmonella PAPs have the typical four-domain organization
of RND-associated PAPs (as in Fig 1C) with clear domain boundaries and produced reliable
structural alignments, with correspondingly high-confidence scores of the resulting homology
models (S2A Fig). The overall identity between each PAP and the template ranged from 92%
for AcrA to below 30% for the MdsA. The protein sequence identity between AcrA and AcrE
was 69.3% but structural alignments showed an almost identical secondary structure, with
clear domain boundaries and a predicted RMSD of AcrA and AcrE is below 0.5 Å over the full
length C-alpha backbone; the corresponding figure for AcrA and MdtA over the core 4
domains is within 0.6 Å (S2B Fig), which is indicative of a very close structural match, although
such figures need to account for a possible model bias.
The sequence analysis indicates that the PAPs fall into two subfamilies; while AcrA and
AcrE are closely related and form a single phylogenetic branch, both MdtA and MdsA are
approximately equidistantly removed from them, with MdsA revealed to be the most divergent
amongst the Salmonella PAPs (S2A Fig). As a result MdsA was modelled based on the MexA
Fig 3. The 3D-binding sites of PAPs relative to the RND-transporter can be reduced to discrete linear sequence “binding boxes”. A. A multiple sequence alignment
of the 4 Salmonella PAPs combined with the structural alignment of the experimental E. coli AcrA structure (based on 5o66.pdb chainG) (top) reveals clear domain
boundaries and correspondingly high likelihood of secondary structure conservation. Identical residues are coloured red. The proposed “binding boxes” are annotated
from 1 to 9 and delineated using rectangles. Figure produced using Espript. B. Mapping of the binding boxes (in blue) onto the 3D structure of the PAPs (AcrA) shows
that they are restricted solely to β-barrel and MPD domains and map predominantly to one face of the PAP protomer, which faces the RND transporter. C. A Consurf
sequence conservation map based on the 150 unique PAP sequences (sequence identity from 95% to 45%) projected onto the AcrA structure. Highly conserved residues
are indicated with deep magenta, hypervariable regions in cyan. D. A composite image combining the Consurf map from 3C with the space-fill representation of the
residues comprising the binding boxes, demonstrating the strong conservation of the sequence elements within them.
https://doi.org/10.1371/journal.ppat.1008101.g003
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structure as it was the most closely related template with 31.9% identity. A structural overlay of
the models of AcrA, AcrE and MdtA is shown in S2B Fig. In particular the overall structure of
the β-barrel and MP domain is conserved across the family along with the α-hairpin domain
tips which are presumed to interact with the OMF TolC–notably the important ‘RLSD” signa-
ture sequence is present in all of them [41] (S2 Fig).
Conservation analysis of the binding boxes reveals that they are conserved
within functional subfamilies but are strongly divergent outside
Comparison of the annotated ‘binding boxes’ in each of the four Salmonella PAPs revealed
that residues involved in the RND-transporter binding differ between the PAPs subfamilies
[42] (Fig 3A and 3B); the binding boxes of AcrA and AcrE are virtually identical while both
MdtA and MdsA differ markedly at these sites. Importantly however, the position of these
boxes are conserved across the family, have a similar length and are predicted to keep their ori-
entation relative to the transporter in different PAP-RND pairs (S2 Fig). This suggests position
is key to function and specific residues define specificity.
We then mapped the conservation of sequence onto the structural model of Salmonella
AcrA (Fig 3C) and superposed that with the information from the structural analysis of
AcrA-AcrB cryo-EM structures that provided the list of interacting residues. The resulting
composite (Fig 3D) shows a very strong correlation of conservation in the regions that are con-
tacting the RND transporter within a given family of PAPs. Notably, when we expand the
homology search, the residues facing the RND transporters seem to lose their high conserva-
tion scores. This is consistent with the evolutionary requirements for preservation of the con-
tacts within a PAP-transporter pair.
In combination with the conservation analysis, the structural mapping of binding interfaces
strongly suggests that the discrete “binding boxes” observed above provide the primary mecha-
nism for differentiation between functional PAP-transporter pairs. We therefore reasoned that
these sequence differences, should be readily translated into restriction of binding between the
different PAPs which could be detected in functional complementation experiments. Specifi-
cally, based on conservation of the binding boxes between Salmonella AcrA and AcrE we
hypothesised that these two PAPs would show promiscuity and interoperability, while the dif-
ferences observed between AcrA and both MdtA and/or MdsA would preclude their
complementation.
Strains lacking multiple PAPs have reduced efflux, are more susceptible to
antimicrobials and have reduced virulence
In the first instance, to investigate this hypothesis we systematically constructed mutants of
Salmonella lacking each single PAP and every combination of two, three and four PAPs
(Table 1). The only single PAP deletion to alter antimicrobial susceptibility was that of acrA
while single deletions of acrE, mdtA or mdsA (SE04, SE05 or SE06, respectively) did not alter
antimicrobial susceptibility nor effect the rate of efflux of ethidium bromide (Fig 4A). Mutants
lacking two or three PAPs only had an altered phenotype if acrA was deleted. A strain with
intact acrA but lacking all three of the other PAPs (acrE, mdtA and mdsA) had the same anti-
microbial susceptibility phenotype as the wildtype strain (Table 1) showing that presence of
AcrA was sufficient to support normal efflux function in these conditions, presumably through
AcrB.
As shown previously, inactivation of both acrA and acrE together had an additive effect; an
acrAE double knockout was significantly more susceptible than either of the single knockouts
to ethidium bromide and oxacillin and, to a lesser extent but reproducibly, more susceptible to
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crystal violet, fusidic acid, methylene blue, norfloxacin, novobiocin and streptomycin
(Table 1). This correlated with significantly slower efflux of ethidium bromide (Fig 4A). This
suggests that when acrA is deleted that AcrE may be partially complementing the mutant phe-
notype because additional loss of AcrE increased the phenotypic severity in the mutant. No
other combination of double PAP deletions had an additive effect compared to the effect of
losing only AcrA. Furthermore, deletion of a third PAP from a strain lacking acrA and acrE or
deletion of all four PAPs (Δ4PAP) did not further change the phenotype compared to the dou-
ble acrA acrE mutant in terms of antimicrobial susceptibility or efflux rate (Fig 4A and
Table 1).
RND efflux provides an intrinsic basal level of resistance to substrate antibiotics. Lack of
either acrB or tolC reduced the frequency with which mutants with decreased susceptibility to
substrate antibiotics can be selected but this has not been studied in the absence of the PAPs
[43, 44]. Inactivation of the gene coding for the major PAP, acrA, significantly reduced the fre-
quency of selection of mutants with deceased susceptibility to ciprofloxacin while inactivation
of acrE did not. The frequency was also reduced in mutants lacking acrA and acrE or all four
PAPs (Δ4PAP, SE10) although the mutant selection frequency was not significantly different
from that of the single acrA knockout (Fig 4C).
RND efflux is required for virulence in Gram negative bacteria [45]. Deletion of either the
major RND pump AcrB or the PAP AcrA significantly increased survival of the Galleria wax
moth larvae model of infection compared to wild type (53.0% and 46.7% compared to 13.3%,
respectively) (Fig 4B). Single deletion of acrE, mdtA or mdsA did not significantly alter Galleria
survival compared to WT (S5A Fig). Importantly, deletion of acrA and acrE had an additive
effect causing Salmonella to lose the ability to kill the larvae with larval survival increasing to
100%. Strains lacking three or four PAPs were also avirulent in this model. This pattern was
confirmed for selected strains in the mouse model of infection. CFU were enumerated from
Table 1. Antimicrobial susceptibility in strains lacking all combinations of one, two, three or four PAPs.
Strain Cip Nal Chl Tet Eryth Fus Novo Oxa Strep Acr CV EthBr MB Rho 6G
WT (SL1344) SE01 0.015 4 4 2 64 1024 1024 512 8 128 64 1024 1024 1024
ΔacrB SE02 0.008 1 0.5 0.5 4 8 4 4 8 16 4 64 32 8
ΔacrA SE03 0.008 1 1 0.5 2 8 4 8 8 16 4 64 32 16
ΔacrE SE04 0.015 4 4 2 64 1024 512 512 8 128 64 1024 1024 1024
ΔmdsA SE05 0.015 4 4 2 64 1024 512 512 8 128 64 1024 1024 1024
ΔmdtA SE06 0.03 4 4 2 64 1024 512 512 8 128 64 1024 1024 1024
ΔacrA ΔacrE SE07 0.008 1 0.5 0.5 4 4 2 0.5 4 16 2 16 16 8
ΔacrA ΔmdsA SE20 0.008 1 1 0.5 4 8 4 4 8 32 4 64 32 16
ΔacrA ΔmdtA SE21 0.008 1 1 0.5 4 8 4 4 8 32 4 64 32 16
ΔacrE ΔmdsA SE15 0.03 4 4 2 64 1024 512 512 8 128 64 1024 1024 1024
ΔacrE ΔmdtA SE16 0.03 4 4 2 64 1024 512 512 8 128 64 1024 1024 1024
ΔmdsA ΔmdtA SE257 0.015 4 4 2 64 1024 512 512 8 128 64 1024 1024 1024
ΔacrA ΔacrE ΔmdsA SE08 0.008 1 0.5 0.5 4 8 2 0.5 4 16 2 8 16 8
ΔacrA ΔacrE ΔmdtA SE09 0.008 1 0.5 0.5 4 8 2 0.5 4 16 2 32 16 8
ΔacrA ΔmdsA ΔmdtA SE22 0.008 1 0.5 0.5 4 8 4 4 8 16 4 64 32 16
ΔacrE ΔmdsA ΔmdtA SE17 0.015 4 4 2 64 1024 512 512 8 128 64 1024 1024 1024
ΔacrA ΔacrE ΔmdsA ΔmdtA SE10 0.008 1 1 0.5 4 8 2 0.5 4 16 2 16 16 8
Cip, ciprofloxacin; Nal, nalidixic acid; Chl, chloramphenicol; Tet, tetracycline; Amp, ampicillin; Eryth, Erythromycin; Fus, fusidic acid; Novo, novobiocin; Oxa,
oxacillin; Strep, streptomycin; Acr, acriflavine; CV, crystal violet; EthBr, ethidium bromide; MB, methylene Blue; Rho 6G, rhodamine 6G.
https://doi.org/10.1371/journal.ppat.1008101.t001
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liver and spleen three days after intraperitoneal injection. The number of CFU per liver/spleen
was not significantly changed after deletion of only acrA, but was significantly reduced upon
deletion of acrA and acrE or deletion of all 4 PAPs (S5B Fig).
RND efflux is also required for biofilm formation so the ability of the mutants to form bio-
film was added. None of the PAP mutants tested had a significantly altered ability to form bio-
film in our model (S5C Fig).
Together these data support the structural analysis suggesting interoperability of AcrA and
AcrE but not MdtA and MdsA because the effect of inactivating acrA and acrE was additive
but this was not true for mdtA or mdsA.
Fig 4. The effect of loss of combinations of PAPs on the phenotype of Salmonella. A. Efflux of ethidium bromide in strains lacking single or combinations of PAPs.
Bacteria were treated with ethidium bromide and CCCP for 60 min and then re-energized with glucose. Data presented is the time taken for the fluorescence to
decrease by 25% +/- SE. (Data for 10% and 50% drop can be seen in S1 Table) B. Survival of Galleria mellonella wax moth larvae infection model. C. The frequency of
resistance to ciprofloxacin. Data is displayed as the mean of at least 14 biological replicates +/- SE. Data analysed by one-way ANOVA and strains whose frequency of
resistance was significantly different (p<0.05) from SL1344 are indicated by �.
https://doi.org/10.1371/journal.ppat.1008101.g004
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Only AcrA or AcrE can complement the Δ4PAP mutant phenotype
To investigate the hypothesis that AcrA and AcrE would be interoperable, but that MdtA and
MdsA would not, the Δ4PAP strain was separately complemented with plasmids encoding one
of the four PAPs. Under standard laboratory conditions the major pump AcrB is expressed at
much higher levels than any of the other RND pumps and inactivation of the other pumps
does not alter antimicrobial susceptibility, so any complementary effect seen following PAP
expression seen will be meditated by forming a complex the AcrB pump.
Complementation of the Δ4PAP strain with pET20b acrA increased MICs of most antimi-
crobials compared with the Δ4PAP strain although not to wildtype levels (Table 2). This is
unsurprising as complementation with acrA presumably restored function of the major
AcrAB-TolC efflux pump. As suggested by the structural predictions, complementation with
the secondary PAP, AcrE, was also able to increase the MIC of many of the same antimicrobi-
als and dyes including acriflavine, ethidium bromide, methylene blue, novobiocin and rhoda-
mine 6G although in some cases to lower levels than following complementation with acrA.
Complementation of the Δ4PAP strain with pET20b mdtA or pET20b mdsA did not alter
Table 2. Antimicrobial susceptibility following complementation of the Δ4PAP strain with each individual PAP.
MIC μg/ml
Strain Cip Nal Chl Tet Acr Amp CV EthBr Eryth Fus MB Novo Rho 6G
WT SE01 0.015 4 4 2 128 2 64 >1024 64 >1024 >1024 1024 >1024
ΔacrA ΔacrE ΔmdsA ΔmdtA (Δ4PAP) SE10 <0.008 1 1 0.5 16 0.12 2 16 4 8 16 2 8
Δ4PAP + pET20b EV SE25 <0.008 1 1 0.5 16 >16 2 16 4 8 16 2 8
Δ4PAP + pET20b acrA SE26 <0.008 1 2 0.5 64 >16 8 256 32 256 256 32 256
Δ4PAP + pET20b acrE SE31 <0.008 1 1 0.5 64 >16 8 256 8 32 256 16 64
Δ4PAP + pET20b mdsA SE32 <0.008 1 1 0.5 16 >16 2 16 4 8 16 2 8
Δ4PAP + pET20b mdtA SE33 <0.008 1 1 0.5 16 >16 2 16 4 8 16 2 8
Δ4PAP +pTrc acrE SE12 0.015 4 4 2 128 >16 32 >1024 32 >1024 >1024 1024 >1024
Cip, ciprofloxacin; Nal, nalidixic acid; Chl, chloramphenicol; Tet, tetracycline; Amp, ampicillin; Eryth, Erythromycin; Fus, fusidic acid; Novo, novobiocin; Strep,
streptomycin; Acr, acriflavine; CV, crystal violet; EthBr, ethidium bromide; MB, methylene Blue; Rho 6G, rhodamine 6G.
https://doi.org/10.1371/journal.ppat.1008101.t002
Fig 5. Efflux of ethidium bromide. Bacteria were treated with ethidium bromide and CCCP for 60 min and then re-
energized with glucose. Data presented is the time taken for the fluorescence to decrease by 25% +/- SE. (Data for 10%
and 50% drop can be seen in S1 Table). A. Shows data for the Δ4PAP strain with and without complementation of
single PAPs B. Shows data for Δ4PAP that also lacks AcrB or AcrF with and without complementation with acrA or
acrE.
https://doi.org/10.1371/journal.ppat.1008101.g005
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susceptibility to any of the agents tested suggesting that these two PAPs are not able to form
promiscuous interactions with AcrB even when over-produced compared to normal expres-
sion level.
One might expect that the effect of expressing acrE from the plasmid in the Δ4PAP strain
should be the be the same as strain SE22 which lacks acrA, mdtA and mdsA but still has its
chromosomal copy of acrE intact but this is not the case. This is likely because the level of acrE
produced from the pET20b construct represents over-expression compared to the level pro-
duced from the chromosomal copy in wildtype and also in SE22. This shows that the extent of
the complementation is therefore heavily dependent on how much of the AcrE protein is pres-
ent. To investigate the effect of this further acrE (and each of the other PAPs) was cloned into a
higher copy plasmid (pTRC) and this revealed different patterns. As previously described, very
high level over-expression of acrA was tolerated poorly by the cell, causing slow growth rate,
filamentation and no phenotypic complementation (S1 Table and S6 Fig) [19]. The greater
level of AcrE expression was able to complement the antimicrobial susceptibility phenotype of
the Δ4PAP strain to the same level as the wild type and for a greater range of antimicrobials
and dyes including erythromycin, fusidic acid and nalidixic acid and restored efflux of ethid-
ium bromide (Table 2 and Fig 5A). In other words either AcrA or a high level of AcrE, is able
to complement the phenotype caused by lack of all four PAPs. However, even when produced
at this much higher level, neither MdtA or MdsA provided any complementation of efflux
phenotype of the Δ4PAP mutant confirming the hypothesis that they are not capable of form-
ing the same promiscuous or redundant interactions as AcrA or AcrE.
AcrE can function with AcrB
In the strains used for the complementation experiments only the gene coding for the PAP
was cloned into the plasmid and over-expressed, not the RND pump. Given that under stan-
dard laboratory conditions the major pump AcrB is expressed at much higher levels than its
homologue AcrF and that inactivation of acrE, acrF or acrEF does not alter antimicrobial sus-
ceptibility, it seemed likely that overexpression of AcrE could be exerting its complementary
effect by working with the AcrB pump rather than, or as well as, its native AcrF system. In
order to confirm this strains were constructed that lacked all four PAPs and one of the pump
genes, acrB or acrF. These quintuple knockouts were complemented with plasmids encoding
one the PAPs, either acrA or acrE. Deleting the genes coding for either of the pumps AcrB or
AcrF in a strain already lacking all 4 PAPs did not have a significant impact on the antimicro-
bial susceptibility, presumably because the lack of PAPs has already rendered these pumps
non-functional (Table 3). Complementation with either acrA or acrE was not able to increase
MICs if AcrB was absent suggesting that it is the AcrB pump that is the major mediator of res-
cue in the complementation experiments, not AcrF. Crucially, complementation with acrE still
increased MICs to substrate antibiotics, increased efflux rate and decreased accumulation of
ciprofloxacin even in the absence of its cognate pump, AcrF, while in the absence of AcrB it
could not (Table 3 and Figs 5B and S6C). This shows that AcrE is exerting its complementary
effect by interaction with AcrB as well as, or instead of, AcrF.
In the absence of AcrA it is possible for select for AcrE over-expression
The fact that AcrE is able to function with AcrB in the absence of AcrF potentially complicates
the issue of finding inhibitors of the PAPs as it suggests that there is potential for resistance to
an inhibitor targeted only to AcrA to occur by increased expression of AcrE. In order to see if
this is a possibility the mutants with decreased ciprofloxacin susceptibility selected from the
acrA mutant (Fig 4C) were studied to determine the mechanism of decreased susceptibility.
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The most common mechanism of resistance to fluoroquinolones is mutations within the quin-
olone resistance determining region (QRDR) of the gyrA gene and more rarely in gyrB [46].
The QRDR of gyrA was sequenced in some of the selected mutants and selected strains are
shown in Table 4. The majority of selected mutants had well described gyrase mutations (e.g.
D87G, S83F) explaining their decreased ciprofloxacin susceptibility. However, one mutant,
M15, had no gyrA or gyrB mutations but had increased MICs to ciprofloxacin and other fluo-
roquinolones and also to ampicillin and erythromycin which are well characterised substrates
Table 3. Antimicrobial susceptibility in Δ4PAP strain also lacking major pumps AcrB or AcrF and complemented with acrA, acrE, mdtA or mdsA.
MIC μg/ml
Nal Chl Tet Amp Eryth Fus Novo Strep Acr CV EthBr MB Rho 6G
WT SE01 4 4 2 2 64 >1024 1024 8 128 64 >1024 >1024 >1024
ΔacrA ΔacrE ΔmdsA ΔmdtA (Δ4PAP) SE10 1 1 0.5 0.12 4 8 2 4 16 2 16 16 8
Δ4PAP ΔacrF SE141 1 1 0.5 0.12 4 8 2 4 16 2 8 8 8
Δ4PAP ΔacrB SE143 1 1 0.5 0.12 4 8 1 4 16 2 8 8 8
Δ4PAP ΔacrF +pTrc acrA SE168 4 4 1 >16 32 512 256 4 128 16 >1024 >1024 >1024
Δ4PAP ΔacrB +pTrc acrA SE176 1 0.5 0.5 >16 4 8 1 4 16 2 8 8 8
Δ4PAP ΔacrF +pTrc acrE SE169 4 4 1 >16 32 >1024 512 4 128 32 >1024 >1024 >1024
Δ4PAP ΔacrB +pTrc acrE SE177 1 0.5 0.5 >16 4 8 1 4 16 2 8 8 8
Δ4PAP ΔacrF+ pTrc mdsA SE170 1 0.5 0.5 >16 2 8 1 4 16 2 8 8 8
Δ4PAP ΔacrB + pTrc mdsA SE178 1 0.5 0.5 >16 2 8 1 4 16 2 8 8 8
Δ4PAP ΔacrF+ pTrc mdtA SE171 1 0.5 0.5 >16 2 4 1 4 16 2 8 8 8
Δ4PAP ΔacrB + pTrc mdtA SE179 1 0.5 0.5 >16 2 8 1 4 16 2 8 8 8
Δ4PAP ΔacrF + pET20b acrA SE172 2 2 0.5 >16 32 256 32 4 64 8 128 256 256
Δ4PAP ΔacrB + pET20b acrA SE180 2 0.5 0.5 >16 4 8 2 4 32 2 16 8 8
Δ4PAP ΔacrF + pET20b acrE SE173 2 1 0.5 >16 8 16 16 4 32 8 128 128 64
Δ4PAP ΔacrB + pET20b acrE SE181 1 0.5 0.5 >16 4 8 1 4 16 2 8 8 8
Δ4PAP ΔacrF + pET20b mdsA SE174 1 0.5 0.5 >16 4 8 1 4 16 2 8 8 8
Δ4PAP ΔacrB + pET20b mdsA SE182 1 0.5 0.5 >16 4 8 1 4 16 2 8 8 8
Δ4PAP ΔacrF + pET20b mdtA SE175 1 0.5 0.5 >16 4 8 2 4 16 2 8 8 8
Δ4PAP ΔacrB + pET20b mdtA SE183 1 0.5 0.5 >16 4 8 1 4 16 2 8 8 8
Cip, ciprofloxacin; Nal, nalidixic acid; Chl, chloramphenicol; Tet, tetracycline; Amp, ampicillin; Eryth, Erythromycin; Fus, fusidic acid; Novo, novobiocin; Strep,
streptomycin; Tric, triclosan; Acr, acriflavine; CV, crystal violet; EthBr, ethidium bromide; MB, methylene Blue; Rho 6G, rhodamine 6G.
https://doi.org/10.1371/journal.ppat.1008101.t003
Table 4. Antimicrobial susceptibility of ciprofloxacin selected mutants in a ΔacrA background and corresponding gyrA genotype.
Strain MIC (μg/ml) gyrA mutation
Cip Nal Amp Eryth
SL1344 (WT) 0.03 1 256 4 -
ΔacrA (SE3) <0.008 1 0.25 4 -
M15 (ΔacrA) 0.12 16 2 128 None
M16 (ΔacrA) 0.015 64 0.25 2 D87G
M17 (ΔacrA) 0.03 64 0.25 2 D87G
M18 (ΔacrA) 0.06 64 0.25 4 S83F
M19 (ΔacrA) 0.03 64 0.25 4 D87G
M20 (ΔacrA) 0.06 32 0.25 4 D87G
Cip, ciprofloxacin; Nal, nalidixic acid; Amp, ampicillin; Eryth, Erythromycin.
https://doi.org/10.1371/journal.ppat.1008101.t004
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of RND efflux. In addition, despite lacking acrA M15 appeared to have restored efflux as it
accumulated similar levels of the Hoechst dye and had similar efflux kinetics as the wild type
strain (Fig 6A and 6B). The genome of SE03 (ΔacrA) and M15 were sequenced and revealed a
36bp duplication including part of the DNA binding region ramR in M15 (Fig 6C). RamR is a
TetR family transcription factor that negatively regulates expression of the transcription factor
araC family regulator RamA, which promotes expression of acrAB. RT-PCR revealed that in
M15 expression of ramA was increased by 76 fold, presumably due to the non-functional
RamR protein. In addition, transcription of the gene coding for the secondary PAP acrE was
increased by 95 fold and its cognate RND pump acrF was increased by 77 fold (Fig 6D).
Importantly, this shows that in the absence of acrA, it was possible to select for a mutant with
Fig 6. Efflux activity in M15 is restored due to increased expression of acrEF. A. Ethidium bromide efflux. B.
Hoechst accumulation. C. Schematic of RamR with duplication marked by red box d. Real-time reverse transcriptase
PCR. Data from A and B are the mean of three biological replicates +/- SE mean.
https://doi.org/10.1371/journal.ppat.1008101.g006
Table 5. Antimicrobial susceptibility of ciprofloxacin selected strain M15 and derivatives.
MIC μg/ml
Strain Fluoroquinolones Other efflux substrate antibiotics Dyes
Cip Nal Levo Moxi Nor Chl Amp Eryth Fus Novo Oxa Acr CV EthBr MB Rho 6G
WT (SL1344) SE01 0.015 4 0.06 0.06 0.12 4 2 64 >1024 1024 512 128 64 >1024 >1024 >1024
ΔacrA SE03 <0.008 1 0.03 <0.008 0.03 1 0.12 2 8 4 8 16 4 64 32 16
M15 (ΔacrA) SE186 0.06 8 0.25 0.12 0.5 8 4 128 >1024 1024 1024 256 64 >1024 >1024 >1024
M15 acrB::aph SE262 0.03 8 0.25 0.12 0.25 8 2 64 >1024 256 1024 256 32 >1024 >1024 >1024
M15 acrF::aph SE263 0.03 8 0.25 0.12 0.25 8 4 128 >1024 512 1024 256 64 >1024 >1024 >1024
Cip, ciprofloxacin; Nal, nalidixic acid; Levo, levofloxacin; Moxi, moxifloxacin; Nor, norfloxacin; Chl, chloramphenicol; Amp, ampicillin; Eryth, Erythromycin; Fus,
fusidic acid; Novo, novobiocin; Oxa, oxacillin; Acr, acriflavine; CV, crystal violet; EthBr, ethidium bromide; MB, methylene Blue; Rho 6G, rhodamine 6G.
https://doi.org/10.1371/journal.ppat.1008101.t005
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increased expression of a homologous PAP/pump and that this was sufficient to complement
the mutant phenotype back to wildtype levels.
The very high level over-expression of ramA in M15 led to increased expression of acrB and
both acrE and acrF. The acrB and acrF genes were each inactivated in M15 to elucidate
whether the efflux restoration detected in this strain was due to high levels of the AcrE/AcrF
pair or if promiscuous interactions between AcrE and AcrB were also important for exerting
this effect. Inactivation of acrF in M15 (ΔacrA ΔacrF) did not alter the susceptibility to the anti-
microbials tested compared to the M15 parent suggesting that the high level of AcrE protein
present must be working with the AcrB pump to provide efflux function (Table 5). Inactivation
of acrB slightly, but reproducibly, reduced MICs to substrate antibiotics. Together this suggests
that AcrE/AcrB interactions are the main mediator of the rescued efflux ability in M15 but
that AcrE/AcrF complexes are also important.
Together this data validates our structural predictions that AcrA and AcrE can function
interchangeably but that MdtA and MdsA do not possess this interoperability. In addition, we
have shown that this is biologically relevant because in the absence of AcrA function it is possi-
ble to select for compensation by increased expression of AcrE whose binding box sequences
were most conserved.
Site directed mutagenesis validates the critical roles of the binding boxes
To further validate the roles of the newly defined sequences boxes we targeted both the most
conserved (suggested to form PAP family-wide docking sites) and non-conserved residues
(expected to act as discriminators between different PAP-transporter pairs) by site directed
mutagenesis followed by quantitative EtBr efflux assay (Fig 7A) and measurement of antimi-
crobial susceptibility (S2 Table). Mapping of the mutations onto the structure of the AcrABZ--
TolC complex [24] is presented in Fig 7B with the mutations with the statistically significant
impact on the efflux function coloured magenta. Significantly most of the boxes appear to have
a measurable effect on function, with mutations affecting the conserved residues in box 1
(G58F), box 4 (TT270-271FF; GS272-273PP); box 5 (F292G; R294F) and box 9 (G363F) being
comparable to the phenotype of the Δ4PAP strain, while measurable impact can also be
detected for mutations affecting box 6 (R318A), and intriguingly, mutations in some PAP resi-
dues which are predicted to only make contact with the RND transporter in one of the two
protomers had a measurably impaired efflux–notably PAP1-specific Q310F (PAP1 specific
pre-box 6) (see additional comments in the S1 Text). To validate that the observed effects are
not due to changes in protein expression levels or stability of the products we introduced a C-
terminal His-tag reporter and quantified protein levels using Western blotting (Fig 7C).
Structural mapping of the mutations revealed that with the exception of the G363 (box 9),
the rest of the detrimental mutations belong to β-barrel domain residues of the PAP forming a
tight cluster around the β-hairpins (DN and DC respectively) of the AcrB funnel domain,
which provides the largest buried surface on the PAP-RND complex. Consistent with this, the
mutations within rest of the boxes, that are less conserved and make lower number of interac-
tions with RND protomers had very limited impact on the efflux function.
Discussion
The RND efflux pumps are an attractive target for inhibition due to their crucial roles in anti-
biotic resistance, virulence and biofilm formation [e.g. 7, 8, 9, 47]. Several molecules have been
found that effectively inhibit RND efflux but for various reasons none of them have progressed
to the clinic [48]. One strategy being explored to inhibit efflux is to target the PAP which we
previously highlighted [18] and more recently two groups have published studies showing that
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inhibition of AcrA by small molecules [21] or by antisense technology [22] was indeed suffi-
cient to inhibit efflux.
However, we also suggested that promiscuity existed between AcrA and AcrE in Salmonella
and that this may have implications for future efflux inhibition strategies [18]. However, until
recently reliable structural information about the full-length PAP structure and particularly
how it links to the RND transporter has limited our ability to rationalise this finding with
structural data and understand how this promiscuity may arise on a molecular level. Recent
major advances in the understanding of RND efflux pump structure [23, 24, 26] provided by
the advent of high-resolution PAP-RND co-complexes allowed us to identify and systematise
the residue ranges involved in PAP-RND binding for the first time. These contact residues
form 4 homologous three-dimensional binding sites within each PAP protomer, that translate
into 9 discrete linear “binding boxes” which are readily identifiable in multiple sequence align-
ments (Fig 3A). Furthermore, as reported above we demonstrate that PAP residues predicted
to be in contact with the surface of the transporter protein are generally well conserved within
the related efflux families suggesting evolutionary pressure for preservation of the contacts
Fig 7. A. Efflux of ethidium bromide by strains complemented with mutated versions of AcrA. Mutants labelled above bar according to which binding box is mutated.
Bacteria were treated with ethidium bromide and CCCP for 60 min and then re-energized with glucose. Data presented are the mean of three independent biological
replicates and are shown as the time taken for the fluorescence to decrease by 50% +/- SE. Data were analysed by one way ANOVA. B. Mapping of PAP box mutations to
the structure of the assembled complex based on the cryo-EM structure of E. coli AcrAB-TolC. The PAP 1 protomer bound to the green RND protomer is colored blue;
PAP 2 protomer is colored red. For clarity the hairpins of both PAP 1 and PAP 2 protomers are removed. Mutations of residues with prominent phenotypic effect on
efflux are colored magenta and the residues responsible are presented in spacefill. Mutations colored orange were responsible for a measurable (although not statistically
significant effect) while mutations in green had no measurable effect. The mapping reveals that the majority of the mutations with a statistically significant effect are
mapping to the beta-barrel domain of the PAP. In particular, it is notable that the efflux-sensitive mutations cluster around the two beta-hairpins at the crown of the
porter domains of the RND-transporter and that the same residues appear to be grasping the hairpin 1 and hairpin 2 respectively in PAP 1 and PAP 2 in a pincer-like
fashion. This finding strongly supports the primary role of the beta-hairpins in the PAP assembly. C. Western Blot analysis of the expression and stability of selected
mutated AcrA constructs with pronounced phenotypic effects. C-terminal His-tagged versions of the proteins were expressed from pET20b in Salmonella Δ4PAP
background and protein expression visualised using a monoclonal anti-His AP-conjugated antibody.
https://doi.org/10.1371/journal.ppat.1008101.g007
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between the PAP-transporter pair (Fig 3C and 3D). A clear demonstration of such positional
residue-conservation linkage can be seen within the MacA PAP family, which form complexes
with the unrelated MacB family of ABC transporters. MacA has the same PAP domain archi-
tecture as the RND associated ones and importantly utilizes the same structural elements and
even residue ranges for binding their cognate transporters although there is very little conser-
vation within the boxes relative to the AcrA-group of PAPs [25].
The observation that there are limited interfaces between the PAP and transporter
restricted to a few “binding boxes” and the requirement for partner pair-recognition between
the PAP and its cognate transporter led us to the straightforward hypothesis of the possible
existence of what we called “discriminator residues”. Under this scenario, the limited area of
the docking sites, requires the existence and maintenance of robust, and consequently con-
served residue pairs, which are responsible for the general docking, while a small subset of resi-
dues within the binding boxes, would fulfil the function of recognising the transporter. Closely
related PAPs such as AcrA and AcrE, that present correspondingly high conservation within
the binding boxes are likely to be able to recognise similar transporters. Thus analysis of the
boxes can hint at the origin of the promiscuity and functional redundancy and interoperability
between the PAPs, while dramatically narrowing the search for the discriminator residues.
Consistent with these predictions we have demonstrated that the AcrA and AcrE can function-
ally complement each other, while the MdtA and MdsA, which function with the significantly
divergent RND-transporters MdsB and MdtB/C respectively, fail to do so, again consistent
with the high discrepancy of their corresponding binding boxes relative to AcrA.
Crucially, the hypothesis of the role of the conserved residues within boxes being critical for
stabilising the structure of the functional tripartite assembly and thus having a measurable
effect on the efflux function has been successfully tested using our site-directed mutagenesis
(Fig 7 and S2 Table). This revealed that conserved residues belonging to boxes 1, 4 and 5,
which create a pseudo-continuous binding site on the surface of the beta-barrel domain are
critical for efflux function, which is consistent with our prediction. Notably the same residue
ranges in PAP 1 and PAP 2 provide the binding in a pincer-like fashion (Fig 7) around each
hairpin, and their apparent tight association is consistent with the primacy of these interac-
tions in maintaining the complex, thus plausibly explaining the impact of the observed muta-
tions. Equally the dramatic effect of mutation of the ultra-conserved G363 residue belonging
to box 9 of the MPD demonstrates the importance of these structural anchors. On the other
hand, and consistent with the expectations, mutations targeting non-conserved boxes (notably
2 and 3), as well as the PAP-conformer specific boxes such as box 7 and 8, along with the
hypervariable residues within box 6 (e.g. R315A) did not have a clearly pronounced pheno-
typic effect.
While these observations have strongly supported the proposed role of the binding boxes,
we furthermore checked the predictive power of our model, by performing an additional
“blind” analysis of the MexA from Pseudomonas aeruginosa, UniProtKB—P52477 (MEXA_P-
SEAE) docking mode to MexB based on the structure of the complex which became available
after the initial submission of this work [49]. As shown in S7 Fig, (with the location of the
tested site-directed mutations in AcrA indicated) despite the evolutionary distance between
Pseudomonas and Salmonella, the structural alignment shows that the boxes align perfectly
between the genera and furthermore critically important conserved residues have retained
their positions within them.
Our identification of the PAP binding boxes, provides a testable hypothesis and a useful
framework for further study of PAP-transporter interaction, and while the extensive mutagen-
esis needed to validate all of them as functional interaction sites goes beyond the remit of the
current study, by defining them we were able to provide startling rationalisation of already
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available data, which lends strong support to this interpretation. For example, previous reports
suggest that while Pseudomonas PAP MexA isn’t able to interact with TolC, thus rendering the
chimeric MexAB-TolC pump inactive [50], the E. coli AcrA appears to be rather promiscuous
and capable of partial interaction with the Pseudomonas RND transporter MexB, and that
interaction can be further improved by point mutagenesis [51]. Intriguingly, the reported
additional AcrA mutations which enabled the TolC-AcrA-MexB pump to gain full function
are all located on a continuous stretch of residues from 240–249 in AcrA, coinciding with the
position of “binding box 3”. The recent cryo-EM structures reveal that the AcrA residues 249–
250 are in sufficient vicinity of the RND-transporter to engage in direct contact. Specifically, in
5O66.pdb D732 and K735 and the carbonyl of A803 provide plausible interaction partners
from the side of the AcrB to PAP2. This is further reinforced by the observation that one of the
MexB adaptive mutations, namely A802V, is located in a position equivalent to the one of
A803 in AcrB (as seen in the superposition of 3W9I.pdb [52] with AcrB), suggesting that
indeed, the AcrA S249N-MexB A802V reported by Krishnamoorthy et al., presents a corre-
lated mutation pair (S8 Fig) that provides restriction of PAP-RND partners [51]. Thus interac-
tion involving AcrA S249 and AcrB serves as a strong verification tool for the accuracy of the
docking of the AcrA-AcrB, and provides a further support for the role of a small number of
residues as check-points of assembly or “discriminators” vetting the incompatible transporters,
and assuring the engagement of the correct cognate ones in agreement with our hypothesis.
Furthermore, previous data on genetic assessment of the role of β-hairpins in the DN and
DC domains of AcrB identified compensatory mutations in AcrA, located within binding
box 2 (namely S219 E. coli AcrA full length numbering); and binding box4 (G272;S273) which
are revealed by current assembly structures to be in contact with the β-hairpins 1 and 2 of the
AcrB DN and DC domains respectively, thus confirming that these binding boxes are directly
involved in the pump recognition and assembly [53]. Furthermore, the critical residue G361,
mutation of which appears to fatally destabilise the AcrAB-TolC assembly [54], is the key con-
served residue within binding box 9 and hence likely plays a crucial structural support role in
the recognition process.
Finally, earlier complete pump-reconstruction efforts relying on in vivo cross-linking have
indicated that only a few residues of AcrA are able to cross-link to AcrB using short-spacer
length reactants [30]. It is striking that most of these residues belong to the boxes described–
residues 55 (box1); 220 (box2); 250 (box3) from β–barrel domain; residues 320 (box 6); 346
(box8) and 376 belonging to the MP domain. Our structural analysis has also provided several
additional insights regarding the PAP-RND interaction and these are discussed in the S1 Text.
AcrA and AcrE were virtually identical across the identified binding boxes while MdsA and
MdtA, which function with the significantly divergent RND-transporters MdsB and MdtB/C
respectively, present a radically different arrangement within the predicted binding sites. This
structural data, led to the hypothesis that AcrA and AcrE would be interoperable but that
MdtA and MdsA would not. Inactivation of AcrA and AcrE together had an additive effect;
compared to loss of just AcrA, efflux activity was reduced, drug susceptibility was increased
and virulence decreased suggesting that AcrE is partially complementing the phenotype of the
AcrA mutant. However, inactivation, MdtA and/or MdsA, in addition to AcrA and AcrE
(Δ4PAP) had no further effect than loss of just AcrA and AcrE and only expression of AcrA or
AcrE was able to rescue the mutant phenotype of a Δ4PAP strain while MdtA and MdsA were
not. Together this supports the hypothesis that conservation/discrimination based on the pre-
dicted binding residues translates into promiscuity or interoperability and redundancy of
PAPs/pumps and directly affects the drug susceptibility profile.
The described promiscuity of AcrA and AcrE may explain why we and others have found
subtly different phenotypes from inactivation of AcrA and AcrB or both AcrAB [e.g. 22]. This
Identifying the interactions driving the RND-PAP recognition
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008101 December 26, 2019 18 / 28
work suggests that when AcrA alone is inactivated, AcrE is partially compensating for its loss.
The phenotypic effect of losing AcrB tends to be slightly more severe. There is some reported
redundancy between AcrB and AcrF with increased expression of one system to compensate
for loss of the other [8, 55]. However, making inactive AcrB protein rather than deleting the
gene did not result in this compensatory expression [56]. The regulation of the different efflux
systems is complex and it is possible that this compensatory expression is also dependent on
other factors.
In addition these data further support the idea that the PAPs could be an effective target
against which to develop efflux inhibitors because inactivation of them increased susceptibility
to a range of antimicrobials; reduced the frequency at which mutants with other resistance
mechanisms could be selected, and reduced virulence. However, we also found that AcrE
over-expression could easily be selected for and phenotypically compensate for the loss of
AcrA in Salmonella and selection for increased expression of homologous efflux systems has
also been described in E. coli [16, 57]. This suggests that inhibition of only a single efflux pump
component, for example AcrA, may not be an effective strategy because homologous compo-
nents can provide PAP function to the major pump AcrB. Our data suggests that, an inhibitor
that inhibits at least AcrA and AcrE would provide greater sensitivity to antibiotics, reduction
in virulence and prevent resistance to the inhibitor occurring by increased expression of
another PAP. However, there was little phenotypic difference between a double AcrAE mutant
to a strain lacking all four PAPs so there may be no requirement to inhibit all members of the
protein family.
To summarise, in this study we have mapped the residues required for binding of the PAP
to the RND pump, identifying critical residues forming discrete “binding boxes”. We further
validated these by showing that PAPs with conserved binding boxes were interoperable while
those with a more divergent sequence were not. The discrete nature of the binding sites pro-
vides a promising rationale for targeting them with inhibitor molecules and thus decoupling
the pumps. This information could also be exploited for creating “designer pumps” with
defined engineered characteristics e.g. for improved bioethanol production. Combined with
functional in vitro analyses, our results suggest a role for PAPs’ β-barrel and MP domains in
vetting productive multidrug-efflux complexes. In addition our analysis highlights regions of
PAPs critical for the transport mechanism of RND pumps in general; rationalizes previous
gain-of-function mutations, and provides the structural basis of PAP-RND recognition,
understanding of which will be important for future inhibitor design.
Materials and methods
Sequence analysis and modelling the structure of the PAPs
Multiple sequence alignments (MSA) were prepared using MAFFT and NJ/UPGMA phylog-
eny algorithms as implemented in MAFFT v.7 server (https://mafft.cbrc.jp/).
Structural annotations of the MSA sequences were done with Espript 3 [58]. The
AcrA-AcrB interaction surfaces were analysed using InterProSurf [59] as implemented in the
Web-server (http://curie.utmb.edu/) using the available cryo-EM structures (5O66.pdb; 5V5S.
pdb and 5NIL.pdb) and the results were further cross-validated manually using Coot [60].
Sequence conservation analysis was performed using ConSurf [61]. Additional structural anal-
ysis and imaging, including figures was performed with Pymol (PyMOL Molecular Graphics
System, Version 1.71 Schro¨dinger, LLC). For the purposes of homology modelling, we
employed I-TASSER [62] in manual mode with assignment of templates and structural
alignment.
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Salmonella AcrA was modelled based on the direct correspondence of the sequence
between it and the experimentally determined partial E. coli structures (2F1M.pdb, residues
53–298) [32] as well as the cryo-EM full-length structures (5O66.pdb chains G and H; 5NG5:E.
pdb; 5V5S:D.pdb) [24] and the full-length structures of the related MexA from P. aeruginosa
(2V4D.pdb; chainC) [30]. The templates used for AcrA, AcrE and MdtA were the MP
domain-containing AcrA E. coli structures: 5O66:G.pdb and 5NIL:G.pdb. Due to the lower
level of sequence identity, MdsA was modeled using the full-length MexA (2V4D:C.pdb).
Strain construction and growth
The acrA, acrB and acrE mutants were constructed previously from Salmonella enterica sero-
var Typhimurium strain SL1344 [9, 18, 47, 63]. Other mutants were constructed using the λ
red recombinase system described previously, antibiotic markers were removed and the pro-
cess repeated to make double, triple, quadruple and quintuple mutants [64]. The PAP genes
were amplified by PCR from SL1344 and cloned into pET21b (Novagen), relying upon leaky
expression to provide low level complementation of mutant strains. Vectors overexpressing
acrA or acrE, were constructed previously and vectors overexpressing mdtA and mdsA were
generated according to manufacturer’s instructions (Invitrogen pTrcHis). Strains were grown
in Luria–Bertani (LB) broth at 37˚C with shaking unless otherwise stated.
Antimicrobial susceptibility
The agar doubling dilution method was used to determine the MICs of various antibiotics and
dyes according to CLSI guidance. All MICs were repeated at least three times and where neces-
sary a modal value is used. All compounds tested were obtained from Sigma, UK.
Hoechst accumulation
The efflux activity of the mutants was assessed by determining the accumulation of the fluores-
cent dye Hoechst H33342 (Sigma, UK) as described previously [65].
Efflux of ethidium bromide
Efflux activity was also assessed by incubating cells in the presence of ethidium bromide and
CCCP. Cells were re-energised and the rate of reduction in fluorescence was measured as pre-
viously described [18].
Ciprofloxacin accumulation
Uptake of ciprofloxacin was measured as previously described [66] with the following adapta-
tions; cultures were grown to an OD600 nm of 0.6, cells were re-suspended in 50 mM potassium
phosphate buffer and a viable count was taken. Fluorescence was read using a black microtitre
tray in a FLUOstar Optima at excitation and emission wavelengths of 280 and 440 nm, respec-
tively. The fluorescence reading was compared to a standard curve and then divided by the via-
ble count to give amount of ciprofloxacin per cell. Data presented are the mean of three
independent biological replicates ±SEM.
Galleria mellonella killing assays. Wax moth (G. mellonella) larvae were purchased from
Livefood UK Ltd. (Rooks Bridge, Somerset, United Kingdom) and were maintained on wood
chips in the dark at 14˚C. They were stored for not longer than 2 weeks. Bacterial infection of
G. mellonella was performed essentially as described by Wand et al [67]. Individual G. mello-
nella were injected with a bacterial load of approximately 1 x 104 CFU. The data were analyzed
by the Mantel-Cox method using Prism software version 6 (GraphPad, San Diego, CA, USA).
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Mouse infection studies
Wild-type BALB/c mice were purchased from HO Harlan Olac Ltd (Bicester, United King-
dom). The mice were maintained under standard animal housing conditions in accordance
with local and UK Home Office regulations. Overnight cultures of Salmonella strains for infec-
tion studies were inoculated into fresh LB medium at a 1/20 dilution and grown at 37˚C to an
OD600 of 1. The cells from 1 ml of culture were harvested by centrifugation and washed twice
with PBS. The cells were resuspended in 1 ml PBS. Female BALB/c mice (8–10 weeks old)
were injected intraperitoneally (i.p.) with 3x103 CFU. The exact injected dose was confirmed
by plating dilutions of the cell suspension used for infection on LB agar plates. The mice were
sacrificed at 3 days post infection and spleens and livers were retained for analyses. To deter-
mine the bacterial burden in mouse organs, weighed liver and spleen sections were passed
through a 70-μm nylon cell strainer (BD Falcon) with 1 to 5 ml of PBS. The collected cell sus-
pensions were diluted in PBS and plated onto LB agar plates without selection. The recovered
colonies were counted and the bacterial burden per whole organ was calculated.
Biofilm
The ability of mutants to form biofilm was measured using the crystal violet method as
described in [7].
Selection of mutants with decreased susceptibility to fluoroquinolones
Mutant selection experiments were performed with strains SL1344, ΔacrA, ΔacrAE and
ΔacrAΔacrEΔmdsAΔmdtA (Δ4PAP) as previously described [44], using 0.06 μg/ml ciprofloxa-
cin for SL1344 and 0.015 μg/ml for all other strains. At least 12 biological replicates were per-
formed for each strain and the mean frequency of resistance was calculated.
Whole genome sequencing
DNA extraction and WGS was performed by microbes NG, Birmingham. SNPs were identi-
fied relative to SL1344 using Snippy v3.2 (https://github.com/tseemann/snippy).
RNA isolation and RT-PCR
RNA isolation and qRT-PCR were performed as previously described [56] except that the
Total RNA Purification Plus Kit (Norgen) was used, cDNA was synthesized from RNA sam-
ples using FastGene 55-Scriptase (Nippon genetics) and 16S rRNA was used as a housekeeping
gene for data normalisation.
Site directed mutagenesis
Site directed mutagenesis was performed using QuikChange XL mutagenesis kit (Qiagen) and
the StAcrA-pET20b template was used to introduce the mutations. The mutant and WT AcrA
proteins were expressed without induction using the leaky background expression in the
Δ4PAP derivative of the SL1344 strain as described above.
Western blotting
For the purposes of expression testing we introduced a C-terminal His-tag (by QuikChange as
above) into the StAcrA-pET20b harbouring the mutated versions of the AcrA gene. The con-
structs were transformed into Δ4PAP derivative of the SL1344 and protein production induced
with 0.5mM IPTG at OD600 of 0.7. Cells were harvested and lysed in 50mM Tris-HCl 7.5,
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200mM NaCl and 10mM β-DDM (Anatrace), supplemented by Completed EDTA-Free pro-
teinases inhibitor tablets (Roche) using Emulsiflex cell disruptor. Cell debris were removed by
centrifugation at 20,000g and the supernatant separated using 4–12% Bis-Tris precast gradient
SDS-PAGE gel (Invitrogen). Following run the gel was transferred onto PVDF membrane and
visualised by anti-6xHis-tag AP-conjugated antibody (Abcam) and visualised using NBT/
BCIP chromogenic substrate (Sigma).
Supporting information
S1 Fig. Detailed view of the modular organization of the RND transporters on the example
of AcrB. RND transporters, of which AcrB is a prototypical member, are homo-trimeric pro-
teins [68, 69]. In brief, the linear organization of each protomer includes from N- to C-termi-
nus 12 transmembrane (TM) domains, into which (between TM1 and TM2 and between TM7
and TM8 respectively) two large periplasmic loops are spliced. Within each periplasmic loop,
there are non-linear arrangements of subdomains–namely in the N-terminal loop a PN1 sub-
domain, is followed by a split PN2, into which a DN portion of the funnel (or docking) domain
is spliced; which is mirrored by the C-terminal loop: PC1 is followed by a split PC2 into which
the DC portion of the funnel domain is spliced. To complicate matters further these subdo-
mains then create back-to-front functional pairings, that is–PN1 pairs with PC2 to create one
lobe; while PN2 pairs with PC2 to create a second lobe of what is referred to as the porter or
pore-domain (Figs 1A and 1B and S1). Furthermore, the funnel domain is organised in a lego-
like fashion, with pseudo-continuous beta sheets being formed by the core of the domain’s
beta-hairpins (Nβ7-Nβ12 pairing intra-protomer with Cβ8-Cβ9 hairpin) with a contribution
of the beta-hairpins from the next/previous protomer (Nβ8-Nβ9 from neighbouring protomer
pairing with Cβ7-Cβ12 of the core protomer).
(TIF)
S2 Fig. A. Side-by-side comparison of the modelled Salmonella PAPs. Due to the lack of reli-
able structural templates, the N-terminal and C-terminal extensions of MdsA and MdtA
(equivalent to E. coli residue ranges 1–37 and 378–397 in the structural alignment) have not
been modelled. B. Superposed models of the core 4 domains of AcrA (red), AcrE (blue) and
MdtA (blue) show the closely matched fold and a predicted RMSD of below 1.3Å for the entire
C-alpha trace.
(TIF)
S3 Fig. A. Superposition of PAP 1 and PAP2 protomers (on the example of AcrA 5o66.pdb
chain G and chain H—in blue and red respectively), demonstrating the discrepancies of rela-
tive β-barrel domain and MDP domain orientations. Over the whole chain the RMSD is ~1.3
Å; over the MP domain 0.91 Å; β-barrel domain shows the highest individual discrepancy
~1.16 Å; while α-hairpin and lipoyl domains display 0.55 and 0.66 Å RMSD respectively. B.
PAP 1 and PAP2 orientation superposed over β-barrel domain and MDP respectively.
(TIF)
S4 Fig. Superposition of the modelled Salmonella PAPs to illustrate the relative positions
of the binding boxes and the discrepancies between AcrA (red), AcrE (green), MdtA (blue)
and MdsA (yellow). Superposition done over the C-alphas of the β-barrel and MDP domains
respectively. The preservation of the predicted “binding box” interfaces relative to the trans-
porter is evident.
(TIF)
Identifying the interactions driving the RND-PAP recognition
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1008101 December 26, 2019 22 / 28
S5 Fig. The effect of PAP inactivation on A. survival of the Galleria wax moth larvae, the abil-
ity to B. infect the mouse model of infection and C. form biofilm. In the mouse model experi-
ments six animals were infected for each mutant over two independent experiments and the
data pooled. Data were analysed using the Mann Whitney test. The biofilm data is shown as
the mean of three independent biological replicates +/- standard error.
(TIF)
S6 Fig. A. Efflux of ethidium bromide. Bacteria were treated with ethidium bromide and
CCCP for 60 min and then re-energized with glucose. Data presented is the time taken for the
fluorescence to decrease by 25% +/- SE. When produced on pTrc acrA, mdsA and mdtA do
not complement the mutant phenotype. B. Gram stains showing filamentation of the Δ4PAP
strain when acrA is overproduced at a high level but not when acrE is produced at a similar
level. C. Intracellular accumulation of ciprofloxacin. Data is displayed as the mean of at least
three biological replicates each in technical duplicate + SE mean. � denotes a strain with a sig-
nificantly different accumulation of ciprofloxacin compared to SL1344 (p<0.05 following a
two way ANOVA with Dunnett’s multiple comparison test).
(TIF)
S7 Fig. Structural alignment of MexA from Pseudomonas aeruginosa (top) vs the Salmo-
nella and E. coli PAPs discussed before. The secondary structural elements and the corre-
sponding sequence numbering are based on the structure 2V4D.pdb (UniProtKB P52477).
The relative positions of the residues belonging to the binding boxes mutated in the Salmonella
AcrA and their effect are represented by star signs and colours. The alignment demonstrates
that despite the divergent nature of the MexA and the presence of deletions in the sequence
(e.g. at positions 117 and 135 corresponding to the hairpin domain) the overall positions and
sizes of the boxes are identical, and furthermore, the positions of residues with pronounced
effect on efflux are coinciding with the highly conserved residues within the boxes.
(TIF)
S8 Fig. PAP1 vs PAP2 in contact with the transporter showing residues of importance
rationalising the results reported in Krishnamoorthy et al., 2008.
(TIF)
S9 Fig. Mapping of the previously identified RND region involved in discrimination of
cognate PAP–corresponding to AcrB 60–612 in cyan [50] suggests that the DN/PN2
domains are primarily responsible for the recognition of the PAP from the side of the
transporter and correspondingly that PAP2 is primarily involved in transporter recogni-
tion, while PAP1 position may be more promiscuous.
(TIF)
S10 Fig. A: comparison of the PAP1 and PAP2 assembling on the CusA surface (left) and
AcrB surface (right). Note the clear difference in PAP2 interaction with PC1 and PN2
domains. The lipoyl domains in CusBA complex also are much more vertically extended and
present a steeper angle relative to the funnel domain of the transporter. B: Superposition of the
PAP2 orientation in AcrAB complex (red) and CusBA complex–yellow. For clarity the beta-
hairpin domain is removed. While beta-barrel domains are in similar orientation the linker to
the MP domain seems to have undergone a large conformational change as a result of which
the MP domain is interacting primarily with PC1 domain, but appears to have lost the
PN2-domain interactions. Notably the N- and C-termini of the PAP2 in CusBA complex form
extended contacts with the cleft between PC1/PC2 subdomains, which is homologous to the
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entry 2 tunnel of the drug efflux transporters.
(TIF)
S1 Table. Complete strain list with generation time and ethidium bromide efflux where
measured. Data presented is the mean of at least three independent biological replicates +/-
SEM.
(DOCX)
S2 Table. Antimicrobial susceptibility of strains complemented with mutated versions of
AcrA.
(DOCX)
S1 Text. Supplementary results and discussion text.
(DOCX)
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